The board of directors of China Jiuhao Health Industry Corporation Limited announced that, based on preliminary assessment of the latest unaudited consolidated management accounts of the Group, although the Group is expected to generate a net gain of approximately HKD 169 million through the disposal of the 12,196,000 shares in Reorient Group Limited (details of which were disclosed in the Company's announcement issued on 18 June 2015), the Group is expected to record a substantial decrease in net profit for the six months ended 30 June 2015, as compared to a net profit of approximately HKD 95,297,000 for the six months ended 30 June 2014, mainly due to the incurrence of legal and professional fees of approximately HKD 54 million for the very substantial disposal transaction and the potential impairment of certain non-current assets and current assets of the Group including the interests in joint ventures and the amounts due from joint ventures and its subsidiaries.